Total Payments
$4,951
2024 Payments
$778.66
Companies
29
Transactions
250
Medicare Patients
12,797
Medicare Billing
$3.6M
Payment Breakdown by Category
Food & Beverage$4,951 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,951 | 250 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,579 | 85 | $0 (2024) |
| Gilead Sciences, Inc. | $860.63 | 38 | $0 (2024) |
| Lilly USA, LLC | $476.60 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $408.72 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $242.92 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $216.22 | 10 | $0 (2024) |
| Amgen Inc. | $186.96 | 9 | $0 (2019) |
| Global Blood Therapeutics, Inc. | $109.59 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $105.72 | 7 | $0 (2019) |
| PFIZER INC. | $103.89 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $778.66 | 41 | ViiV Healthcare Company ($342.82) |
| 2023 | $994.42 | 50 | ViiV Healthcare Company ($509.71) |
| 2022 | $853.10 | 39 | ViiV Healthcare Company ($443.33) |
| 2021 | $660.88 | 30 | ViiV Healthcare Company ($230.33) |
| 2020 | $445.73 | 22 | Gilead Sciences, Inc. ($169.05) |
| 2019 | $331.17 | 19 | GlaxoSmithKline, LLC. ($85.69) |
| 2018 | $580.44 | 33 | Amgen Inc. ($143.85) |
| 2017 | $307.04 | 16 | Valeant Pharmaceuticals North America LLC ($102.90) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: HIV | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: HIV | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.09 | General |
| 11/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: HIV | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: HIV | ||||||
| 10/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: HIV | ||||||
| 09/26/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: HIV | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: HIV | ||||||
| 08/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.27 | General |
| 08/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: HIV | ||||||
| 08/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/11/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: HIV | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/20/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: HIV | ||||||
| 06/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: HIV | ||||||
| 05/23/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,350 | 10,893 | $2.1M | $892,803 |
| 2022 | 21 | 3,293 | 10,301 | $2.0M | $830,520 |
| 2021 | 18 | 2,849 | 11,570 | $2.1M | $927,641 |
| 2020 | 24 | 3,305 | 12,460 | $2.3M | $992,262 |
Total Patients
12,797
Total Services
45,224
Medicare Billing
$3.6M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 437 | 4,716 | $663,600 | $348,048 | 52.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 737 | 2,983 | $596,600 | $205,581 | 34.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 684 | 751 | $225,300 | $91,594 | 40.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 367 | 490 | $147,100 | $59,545 | 40.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 144 | 511 | $204,400 | $56,808 | 27.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 105 | $40,650 | $21,143 | 52.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 275 | 286 | $34,320 | $20,051 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 250 | $50,000 | $19,668 | 39.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 102 | 118 | $36,200 | $19,065 | 52.7% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 199 | 201 | $46,230 | $14,815 | 32.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 42 | 42 | $14,700 | $7,098 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 49 | $13,475 | $5,655 | 42.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 23 | $6,900 | $5,536 | 80.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 75 | 111 | $16,650 | $3,935 | 23.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 70 | $8,750 | $3,031 | 34.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 44 | $6,600 | $2,330 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,250 | $1,982 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,400 | $1,903 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,250 | $1,487 | 28.3% |
| 90746 | Hepatitis b vaccine, adult dosage (3 dose schedule) | Office | 2023 | 12 | 19 | $2,375 | $1,310 | 55.2% |
| G0010 | Administration of hepatitis b vaccine | Office | 2023 | 18 | 33 | $1,155 | $1,132 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $665.00 | $651.70 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,260 | $368.28 | 29.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 14 | 14 | $560.00 | $63.83 | 11.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 550 | 5,526 | $775,110 | $370,628 | 47.8% |
About Dr. Robert Husney, MD
Dr. Robert Husney, MD is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1235390816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Husney, MD has received a total of $4,951 in payments from pharmaceutical and medical device companies, with $778.66 received in 2024. These payments were reported across 250 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,951).
As a Medicare-enrolled provider, Husney has provided services to 12,797 Medicare beneficiaries, totaling 45,224 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Brooklyn, NY
- Active Since 06/17/2008
- Last Updated 10/10/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235390816
Products in Payments
- CABENUVA (Biological) $1,023
- MOUNJARO (Drug) $294.17
- APRETUDE (Biological) $280.57
- DOVATO (Drug) $274.97
- ELIQUIS (Drug) $267.23
- XIFAXAN (Drug) $208.62
- TRELEGY ELLIPTA (Drug) $162.14
- JANUVIA (Drug) $134.48
- TRULICITY (Drug) $123.81
- BREO (Drug) $109.77
- OXBRYTA (Drug) $109.59
- PIFELTRO (Drug) $108.44
- Prolia (Biological) $85.29
- SHINGRIX (Biological) $62.25
- JARDIANCE (Drug) $58.62
- Aimovig (Biological) $57.69
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $55.19
- UBRELVY (Drug) $47.96
- PreHevbrio (Drug) $47.82
- TUDORZA PRESSAIR (Drug) $46.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095